Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Behr

Showing results (41-50 of 294) with videos related to

Pageof 30
Sort By:
Therapeutic Advances in Infectious Disease|April 2, 2016
The implications of whole-genome sequencing in the control of tuberculosisRobyn S Lee, Marcel A Behr
Expert Review of Clinical Immunology|December 22, 2012
Crohn's as an immune deficiency: from apparent paradox to evolving paradigmDonald C Vinh, Marcel A Behr
Nature Microbiology|July 30, 2021
Emergence of persistent tubercle bacilliFrédéric J Veyrier, Marcel A Behr
Tuberculosis (Edinburgh, Scotland)|August 3, 2007
Rv1773 is a transcriptional repressor deleted from BCG-PasteurDavid C Alexander, Marcel A Behr
The Lancet. Infectious Diseases|August 27, 2022
Estimating annual risk of infection with Mycobacterium tuberculosis - Authors' replyDavid W Dowdy, Marcel A Behr
Plos Pathogens|June 1, 2023
A nod to the bond between NOD2 and mycobacteriaJean-Yves Dubé, Marcel A Behr
American Journal of Respiratory and Critical Care Medicine|August 25, 2021
Individualized Treatment Duration in Tuberculosis Treatment: Precision versus SimplicityMenonli Adjobimey, Marcel A Behr, Dick Menzies
Biochemical and Biophysical Research Communications|August 14, 1981
Apparent pyridine nucleotide synthesis in mitochondria: an artifact of NMN and NAD glycohydrolase activity?A Behr, H Taguchi, R K Gholson
Lancet (London, England)|July 2, 2013
Tuberculosis vaccine trialsMarcel A Behr, Kevin Schwartzman, Madhukar Pai
Cell|February 7, 2012
Innate immunity to TB: a druggable balancing actAjit Lalvani, Marcel A Behr, Saranya Sridhar
Pageof 30

Showing results (41-50 of 294) with videos related to

Sort By:
Pageof 30
Therapeutic Advances in Infectious Disease|April 2, 2016
The implications of whole-genome sequencing in the control of tuberculosisRobyn S Lee, Marcel A Behr
Expert Review of Clinical Immunology|December 22, 2012
Crohn's as an immune deficiency: from apparent paradox to evolving paradigmDonald C Vinh, Marcel A Behr
Nature Microbiology|July 30, 2021
Emergence of persistent tubercle bacilliFrédéric J Veyrier, Marcel A Behr
Tuberculosis (Edinburgh, Scotland)|August 3, 2007
Rv1773 is a transcriptional repressor deleted from BCG-PasteurDavid C Alexander, Marcel A Behr
The Lancet. Infectious Diseases|August 27, 2022
Estimating annual risk of infection with Mycobacterium tuberculosis - Authors' replyDavid W Dowdy, Marcel A Behr
Plos Pathogens|June 1, 2023
A nod to the bond between NOD2 and mycobacteriaJean-Yves Dubé, Marcel A Behr
American Journal of Respiratory and Critical Care Medicine|August 25, 2021
Individualized Treatment Duration in Tuberculosis Treatment: Precision versus SimplicityMenonli Adjobimey, Marcel A Behr, Dick Menzies
Biochemical and Biophysical Research Communications|August 14, 1981
Apparent pyridine nucleotide synthesis in mitochondria: an artifact of NMN and NAD glycohydrolase activity?A Behr, H Taguchi, R K Gholson
Lancet (London, England)|July 2, 2013
Tuberculosis vaccine trialsMarcel A Behr, Kevin Schwartzman, Madhukar Pai
Cell|February 7, 2012
Innate immunity to TB: a druggable balancing actAjit Lalvani, Marcel A Behr, Saranya Sridhar
Pageof 30